JP Patent

JP7108631B2 — ｍＴＯＲ阻害剤の無水組成物およびその使用方法

Assigned to パルヴェラ セラピューティクス、インク． · Expires 2022-07-28 · 4y expired

What this patent protects

Patent listed against Miebo.

Drugs covered by this patent

Patent Metadata

Patent number
JP7108631B2
Jurisdiction
JP
Classification
—
Expires
2022-07-28
Drug substance claim
No
Drug product claim
No
Assignee
パルヴェラ セラピューティクス、インク．
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.